Navigation Links
Mark Rinker Named Vice President of Sales for Blaine Pharmaceuticals

New direction for Blaine Pharmaceuticals

CINCINNATI, Nov. 12 /PRNewswire/ -- Blaine Pharmaceuticals announced today that it has promoted Mark Rinker to Vice President of Sales. Mark will be responsible for all trade relations, market development activities, and sales management as well as evaluating and developing new products to complement the existing Blaine product portfolio.

During his tenure at Blaine Pharmaceuticals, the company has gained significant ground as an over-the-counter (OTC) pharmaceutical company. Blaine's leading product, Mag-Ox 400(R), has expanded distribution in all major food, drug, and mass channels. In 2006, DiaSense(R), a branded line of diabetes supplements was introduced. In 2007, ReliaDose(R) (innovative pediatric medicine delivery system) has been placed in over 27,000 retail locations in the U.S. and internationally.

Mark was hired by Blaine Pharmaceuticals as the Director of International Sales where he helped catapult the company's international presence for Mag-Ox 400(R), DiaSense(R), and ReliaDose(R), in Canada, Japan, South Africa, Central America, Mexico and Korea. Since Mark has been highly involved with the strategic direction of Blaine for the last year, he is armed with knowledge that will be critical in his new position of Vice President of Sales.

Prior to Blaine, Mark served as director of Canadian operations for Omron Healthcare. At Omron, Rinker successfully established Canadian operations. Prior to Omron, Rinker served as a national sales manager with Magna-Pak, Inc., and as a business development manager at Becton Dickinson Canada. Mark graduated from University of Western Ontario with a Bachelor of Administration.

With his new position, Mark will report to Vince Gilday, the Chief Operating Officer. In his new capacity he will work closely with Dreama Kirby, the Chief Marketing Officer to set a strategic direction which focuses on expanding Blaine's market share for its lead products. Now that Blaine has secured significant retail distribution, its objective is to drive the sales of these branded products with considerably more marketing support. These changes within the organization will allow for unprecedented growth of its brands over the next year.

About Blaine Pharmaceuticals

Blaine Pharmaceuticals, founded in 1955, specializes in the development and acquisition of consumer brands with significant value and unrealized potential. Blaine builds sustainable brands by creating consumer demand through recommendations from healthcare professionals. The company's flagship product, Mag-Ox 400(R), is the #1 selling magnesium brand. Other products include the DiaSense(R) family of nutritional supplements and ReliaDose(R), a pediatric medicine-delivery system.

Blaine is committed to cultivating relationships with physicians, pharmacists, patients, wholesalers, retailers, and business partners to build brands and lay the foundation for future endeavors. For more information, visit .

SOURCE Blaine Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
2. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
3. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
4. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
5. New Director of Nursing Practice Named for Nurses Association
6. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
7. Meeting Expectations Named to First Annual CMI 25 List by Corporate Meetings & Incentives Magazine
8. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
9. Keith Taft Named General Manager of UltraTape Industries
10. AIUM CEO named among most influential in radiology
11. Top Twenty Health Plan Websites Named by
Post Your Comments:
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I ... an inventor from Hillside, N.J. "Many people catch diseases simply from sitting on ... will always be protected from germs." , He developed the patent-pending QUDRATECS to ...
(Date:11/27/2015)... ... November 27, 2015 , ... ProSidebar: Fashion is ... Pro X. With ProSidebar: Fasion, video editors can easily add an informative sidebar ... minimalist title opener. Utilize presets featuring self-animating drop zones, lines, bars, and text ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Italian Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/25/2015)... SYDNEY , Nov. 26, 2015  The total global ... nearly 7% over 2015-2016. Latin America ... Asia , (excluding Japan ), is ... continues to face increased healthcare expenditure. In 2013-2014, ... expenditure declined from 43.5% in 2008-2009 to 41.2% in 2013-2014. ...
Breaking Medicine Technology: